Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Malaria Journal

Fig. 2

From: Absence of in vivo selection for K13 mutations after artemether–lumefantrine treatment in Uganda

Fig. 2

Allele prevalence in Pfkelch13, fd, mdr2, arps10, crt, pph and pibp among 61 isolates collected before and after artemether–lumefantrine treatment. Parasite genotypes were characterized at the time of presentation with malaria (day 0) and for infections detected within 28 days after treatment with artemether–lumefantrine (AL). n values represent the number of samples analysed on each day. Wild-type genotypes are indicated

Back to article page